Intra-articular Injection in Arthroscopic Management of Temporomandibular Diseases

Comparative Study Between the Outcome of Intra-articular Injection of Platelet Rich Plasma Versus Hyaluronic Acid in Arthroscopic Management of Temporomandibular Degenerative Joint Diseases: A Randomized Clinical Trial

The aim of this study is to evaluate the efficacy of intra-articular injection of platelet rich plasma versus hyaluronic acid following diagnostic arthroscopy in the management of patients suffering from degenerative temporomandibular joint (TMJ).

This is a prospective randomized study of 20 patients with TMJ degenerative joint diseases Wilkes IV, V.

Patients will be divided into two groups; Group A: will be treated with operative arthroscopy plus intra-articular platelet rich plasma.

Group B: will be treated with operative arthroscopy plus intra-articular hyaluronic acid.

Inclusion Criteria:

• - All patients with reduced mouth opening and/or painful maximum mouth opening.
• Joint pain.
• Patients with radiological evidence of degenerative joint disease.
• Patients with unsuccessful medical conservative treatment for at least two months.
• Unilateral or bilateral temporomandibular joint involvement.
• Wilkes stages IV and V

Exclusion Criteria:

• - Patients with bony ankylosis .
• Patients with advanced resorption of the glenoid fossa.
• Patients with infection or tumors around joint area
• Patients unfit for intervention medically.
• Patients who refused to share in the study